The extent of exposure of the product to the environment, and the available information about the physical/chemical, pharmacological and/or toxicological properties of the substance(s) concerned, including metabolites in case of an identified risk, which has been obtained during the conduct of the other tests and trials required by this Directive, shall be taken into consideration.
Cuirfear san áireamh a mhéid a bheidh an táirge i dteagmháil leis an gcomhshaol agus an fhaisnéis atá ar fáil faoi airíonna fisiciúla/ceimiceacha, cógaseolaíocha agus/nó tocsaineolaíocha na substainte/substaintí lena mbaineann lena n-áirítear meitibilítí i gcás riosca sainaitheanta, a breathnaíodh le linn tástálacha agus trialacha a ceanglaíodh leis an Treoir seo.